Hologic, Inc. (NASDAQ: HOLX) is 11.98% higher on its value in year-to-date trading and has touched a low of $64.02 and a high of $84.67 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HOLX stock was last observed hovering at around $81.96 in the last trading session, with the day’s loss setting it -1.95%.
Currently trading at $80.01, the stock is -1.22% and 0.46% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.59 million and changing -2.38% at the moment leaves the stock 6.12% off its SMA200. HOLX registered 9.92% gain for a year compared to 6-month gain of 5.78%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -2.15% loss in the last 1 month and extending the period to 3 months gives it a 9.75%, and is -1.97% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.89% over the week and 1.42% over the month.
Hologic, Inc. (HOLX) has around 6990 employees, a market worth around $18.58B and $3.99B in sales. Current P/E ratio is 27.30 and Fwd P/E is 18.02. Profit margin for the company is 17.59%. Distance from 52-week low is 24.98% and -5.50% from its 52-week high. The company has generated returns on investments over the last 12 months (9.39%).
The EPS is expected to grow by 3.12% this year
1095.0 institutions hold shares in Hologic, Inc. (HOLX), with institutional investors hold 101.14% of the company’s shares. The shares outstanding are 241.71M, and float is at 229.26M with Short Float at 2.25%. Institutions hold 100.42% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 26.77 million shares valued at $1.99 billion. The investor’s holdings represent 11.3498 of the HOLX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 23.1 million shares valued at $1.72 billion to account for 9.7922 of the shares outstanding. The other top investors are T. ROWE PRICE INVESTMENT MANAGEMENT, INC. which holds 22.46 million shares representing 9.5193 and valued at over $1.67 billion, while STATE STREET CORP holds 4.3784 of the shares totaling 10.33 million with a market value of $766.87 million.
Hologic, Inc. (HOLX) Insider Activity
The most recent transaction is an insider sale by Oberton Karleen Marie, the company’s Chief Financial Officer. SEC filings show that Oberton Karleen Marie sold 52,679 shares of the company’s common stock on Aug 29 ’24 at a price of $80.56 per share for a total of $4.24 million. Following the sale, the insider now owns 84042.0 shares.
Still, SEC filings show that on Aug 06 ’24, Schnittker Brandon (Div. President, GYN Surgical) disposed off 476 shares at an average price of $83.11 for $39559.0. The insider now directly holds 3,735 shares of Hologic, Inc. (HOLX).
